Jun 11, 2021 | COVID-19, News and Updates
On June 11, 2021 the Department of Health and Human Services (HHS) published revised Reporting Requirements for recipients of Provider Relief Fund (PFR) payments. Notably, these revisions have impacted when funds must be used and reporting deadlines for some tranches...
Jun 10, 2021 | 340B, Litigation, News and Updates
On June 10, 2021, Eli Lilly became the third manufacturer to response to HRSA’s May 17th Cease and Desist letter on 340B drug pricing. The response details Eli Lilly’s rejection of HRSA’s reasoning in its Cease and Desist letter, arguing that the agency’s reasoning is...
May 18, 2021 | 340B, Litigation, News and Updates
On May 17, 2021, the Health and Resource Service Administration (HRSA) issued letters to six pharmaceutical manufacturers requiring the entities to immediately cease an ongoing practice of withholding 340B pricing to covered entities utilizing contract pharmacies....
May 17, 2021 | GME, Medicare, News and Updates
A district court in Washington, DC ruled today that a regulation governing the weighting of fellows for purposes of determining certain hospitals’ Medicare resident caps and graduate medical education (GME) payments is unlawful. Originally issued by the Department of...
Apr 8, 2021 | GME, News and Updates
In the Consolidated Appropriations Act of 2021 (CAA), Congress enacted several important changes to the Medicare GME rules governing the calculation of teaching hospitals’ per resident amount (PRA) and full-time equivalent (FTE) resident caps in order to accommodate...
Apr 6, 2021 | News and Updates, Waivers
On April 16, 2021, CMS rescinded its approval of Texas’ 1115 waiver, citing insufficient justification for granting an emergency exemption to the public notice requirements.
